Publications

Publications pour l'équipe Oncostat

Titre Publication Type Publication year Auteur
Mining the coding and non-coding genome for cancer drivers journalArticle 2015 Li, J.; Drubay, D.; Michiels, S.; Gautheret, D.
Mining the coding and non-coding genome for cancer drivers journalArticle 2015 Li, J.; Drubay, D.; Michiels, S.; Gautheret, D.
REBECA: a phase I study of bevacizumab and whole-brain radiation therapy for the treatment of brain metastasis from solid tumours journalArticle 2015 Levy, C.; Allouache, D.; Lacroix, J.; Dugue, A. E.; Supiot, S.; Campone, M.; Mahe, M.; Kichou, S.; Leheurteur, M.; Hanzen, C.; Dieras, V.; Kirova, Y.; Campana, F.; Le Rhun, E.; Gras, L.; Bachelot, T.; Sunyach, M. P.; Hrab, I.; Geffrelot, J.; Gunzer, K.; Constans, J. M.; Grellard, J. M.; Clarisse, B.; Paoletti, X.
REBECA: a phase I study of bevacizumab and whole-brain radiation therapy for the treatment of brain metastasis from solid tumours journalArticle 2015 Levy, C.; Allouache, D.; Lacroix, J.; Dugue, A. E.; Supiot, S.; Campone, M.; Mahe, M.; Kichou, S.; Leheurteur, M.; Hanzen, C.; Dieras, V.; Kirova, Y.; Campana, F.; Le Rhun, E.; Gras, L.; Bachelot, T.; Sunyach, M. P.; Hrab, I.; Geffrelot, J.; Gunzer, K.; Constans, J. M.; Grellard, J. M.; Clarisse, B.; Paoletti, X.
Late toxicity of brachytherapy after female genital tract tumors treated during childhood: Prospective evaluation with a long-term follow-up journalArticle 2015 Levy, A.; Martelli, H.; Fayech, C.; Minard-Colin, V.; Dumas, I.; Gensse, M. C.; Le Deley, M. C.; Oberlin, O.; Haie-Meder, C.
Late toxicity of brachytherapy after female genital tract tumors treated during childhood: Prospective evaluation with a long-term follow-up journalArticle 2015 Levy, A.; Martelli, H.; Fayech, C.; Minard-Colin, V.; Dumas, I.; Gensse, M. C.; Le Deley, M. C.; Oberlin, O.; Haie-Meder, C.
(18)F-fluorodeoxyglucose positron emission tomography to assess response after radiation therapy in anaplastic thyroid cancer journalArticle 2015 Levy, A.; Leboulleux, S.; Lepoutre-Lussey, C.; Baudin, E.; Ghuzlan, A. A.; Hartl, D.; Deutsch, E.; Deandreis, D.; Lumbroso, J.; Tao, Y.; Schlumberger, M.; Blanchard, P.
Low response rate after cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: long-term results of the UNICANCER ACCORD 16 phase II trial journalArticle 2015 Levy, A.; Azria, D.; Pignon, J. P.; Delarochefordiere, A.; Martel-Lafay, I.; Rio, E.; Malka, D.; Conroy, T.; Miglianico, L.; Becouarn, Y.; Malekzadeh, K.; Leclercq, J.; Juzyna, B.; Ezra, P.; Lemanski, C.; Deutsch, E.
Low response rate after cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: long-term results of the UNICANCER ACCORD 16 phase II trial journalArticle 2015 Levy, A.; Azria, D.; Pignon, J. P.; Delarochefordiere, A.; Martel-Lafay, I.; Rio, E.; Malka, D.; Conroy, T.; Miglianico, L.; Becouarn, Y.; Malekzadeh, K.; Leclercq, J.; Juzyna, B.; Ezra, P.; Lemanski, C.; Deutsch, E.
Screening in asymptomatic SDHx mutation carriers: added value of ¹⁸F-FDG PET/CT at initial diagnosis and 1-year follow-up journalArticle 2015 Lepoutre-Lussey, C.; Caramella, C.; Bidault, F.; Déandreis, D.; Berdelou, A.; Al Ghuzlan, A.; Hartl, D.; Borget, I.; Gimenez-Roqueplo, A. P.; Dumont, F.; Deschamps, F.; Nascimento, C.; Lumbroso, J.; Guillaud Bataille, M.; Schlumberger, M.; Baudin, E.; Leboulleux, S.
Screening in asymptomatic SDHx mutation carriers: added value of ¹⁸F-FDG PET/CT at initial diagnosis and 1-year follow-up journalArticle 2015 Lepoutre-Lussey, C.; Caramella, C.; Bidault, F.; Déandreis, D.; Berdelou, A.; Al Ghuzlan, A.; Hartl, D.; Borget, I.; Gimenez-Roqueplo, A. P.; Dumont, F.; Deschamps, F.; Nascimento, C.; Lumbroso, J.; Guillaud Bataille, M.; Schlumberger, M.; Baudin, E.; Leboulleux, S.
[Economic analysis of multinational clinical trials in oncology] journalArticle 2018 Lejeune, C.; Lueza, B.; Bonastre, J.
Human metapneumovirus in patients hospitalized with acute respiratory infections: A meta-analysis journalArticle 2016 Lefebvre, A.; Manoha, C.; Bour, J. B.; Abbas, R.; Fournel, I.; Tiv, M.; Pothier, P.; Astruc, K.; Aho-Glele, L. S.
Human metapneumovirus in patients hospitalized with acute respiratory infections: A meta-analysis journalArticle 2016 Lefebvre, A.; Manoha, C.; Bour, J. B.; Abbas, R.; Fournel, I.; Tiv, M.; Pothier, P.; Astruc, K.; Aho-Glele, L. S.
Radioactive iodine ablation in low-risk thyroid cancer - Authors' reply journalArticle 2018 Leboulleux, S.; Borget, I.; Schlumberger, M.
Prognostic and predictive factors for angiosarcoma patients receiving paclitaxel once weekly plus or minus bevacizumab: an ancillary study derived from a randomized clinical trial journalArticle 2018 Lebellec, L.; Bertucci, F.; Tresch-Bruneel, E.; Ray-Coquard, I.; Le Cesne, A.; Bompas, E.; Blay, J. Y.; Italiano, A.; Mir, O.; Ryckewaert, T.; Toiron, Y.; Camoin, L.; Goncalves, A.; Penel, N.; Le Deley, M. C.
Treatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine Trials journalArticle 2016 Le Tourneau, C.; Kamal, M.; Tsimberidou, A. M.; Bedard, P.; Pierron, G.; Callens, C.; Rouleau, E.; Vincent-Salomon, A.; Servant, N.; Alt, M.; Rouzier, R.; Paoletti, X.; Delattre, O.; Bieche, I.
Treatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine Trials journalArticle 2016 Le Tourneau, C.; Kamal, M.; Tsimberidou, A. M.; Bedard, P.; Pierron, G.; Callens, C.; Rouleau, E.; Vincent-Salomon, A.; Servant, N.; Alt, M.; Rouzier, R.; Paoletti, X.; Delattre, O.; Bieche, I.
Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial journalArticle 2015 Le Tourneau, C.; Delord, J. P.; Goncalves, A.; Gavoille, C.; Dubot, C.; Isambert, N.; Campone, M.; Tredan, O.; Massiani, M. A.; Mauborgne, C.; Armanet, S.; Servant, N.; Bieche, I.; Bernard, V.; Gentien, D.; Jezequel, P.; Attignon, V.; Boyault, S.; Vincent-Salomon, A.; Servois, V.; Sablin, M. P.; Kamal, M.; Paoletti, X.; investigators, Shiva
Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial journalArticle 2015 Le Tourneau, C.; Delord, J. P.; Goncalves, A.; Gavoille, C.; Dubot, C.; Isambert, N.; Campone, M.; Tredan, O.; Massiani, M. A.; Mauborgne, C.; Armanet, S.; Servant, N.; Bieche, I.; Bernard, V.; Gentien, D.; Jezequel, P.; Attignon, V.; Boyault, S.; Vincent-Salomon, A.; Servois, V.; Sablin, M. P.; Kamal, M.; Paoletti, X.; investigators, Shiva
Precision medicine: lessons learned from the SHIVA trial - Authors' reply journalArticle 2015 Le Tourneau, C.; Belin, L.; Paoletti, X.; Bieche, I.; Kamal, M.
Precision medicine: lessons learned from the SHIVA trial - Authors' reply journalArticle 2015 Le Tourneau, C.; Belin, L.; Paoletti, X.; Bieche, I.; Kamal, M.
Flexible modeling of disease activity measures improved prognosis of disability progression in relapsing-remitting multiple sclerosis journalArticle 2015 Le Teuff, G.; Abrahamowicz, M.; Wynant, W.; Binquet, C.; Moreau, T.; Quantin, C.
Intrathecal liposomal cytarabine plus systemic therapy versus systemic chemotherapy alone for newly diagnosed leptomeningeal metastasis from breast cancer journalArticle 2019 Le Rhun, E.; Wallet, J.; Mailliez, A.; Le Deley, M. C.; Rodrigues, I.; Boulanger, T.; Lorgis, V.; Barriere, J.; Robin, Y. M.; Weller, M.; Bonneterre, J.
Prevalence of burnout, depression and job satisfaction among French senior and resident radiation oncologists journalArticle 2018 Lazarescu, I.; Dubray, B.; Joulakian, M. B.; Blanchard, P.; Chauvet, B.; Mahe, M. A.; Mornex, F.; Rocher, F.; Thureau, S.
A simplified interventional mapping system (SIMS) for the selection of combinations of targeted treatments in non-small cell lung cancer journalArticle 2015 Lazar, V.; Rubin, E.; Depil, S.; Pawitan, Y.; Martini, J. F.; Gomez-Navarro, J.; Yver, A.; Kan, Z.; Dry, J. R.; Kehren, J.; Validire, P.; Rodon, J.; Vielh, P.; Ducreux, M.; Galbraith, S.; Lehnert, M.; Onn, A.; Berger, R.; Pierotti, M. A.; Porgador, A.; Pramesh, C. S.; Ye, D. W.; Carvalho, A. L.; Batist, G.; Le Chevalier, T.; Morice, P.; Besse, B.; Vassal, G.; Mortlock, A.; Hansson, J.; Berindan-Neagoe, I.; Dann, R.; Haspel, J.; Irimie, A.; Laderman, S.; Nechushtan, H.; Al Omari, A. S.; Haywood, T.; Bresson, C.; Soo, K. C.; Osman, I.; Mata, H.; Lee, J. J.; Jhaveri, K.; Meurice, G.; Palmer, G.; Lacroix, L.; Koscielny, S.; Eterovic, K. A.; Blay, J. Y.; Buller, R.; Eggermont, A.; Schilsky, R. L.; Mendelsohn, J.; Soria, J. C.; Rothenberg, M.; Scoazec, J. Y.; Hong, W. K.; Kurzrock, R.
Selection of an early biomarker for vascular normalization using dynamic contrast-enhanced ultrasonography to predict outcomes of metastatic patients treated with bevacizumab journalArticle 2016 Lassau, N.; Coiffier, B.; Kind, M.; Vilgrain, V.; Lacroix, J.; Cuinet, M.; Taieb, S.; Aziza, R.; Sarran, A.; Labbe-Devilliers, C.; Gallix, B.; Lucidarme, O.; Ptak, Y.; Rocher, L.; Caquot, L. M.; Chagnon, S.; Marion, D.; Luciani, A.; Feutray, S.; Uzan-Augui, J.; Benatsou, B.; Bonastre, J.; Koscielny, S.
Selection of an early biomarker for vascular normalization using dynamic contrast-enhanced ultrasonography to predict outcomes of metastatic patients treated with bevacizumab journalArticle 2016 Lassau, N.; Coiffier, B.; Kind, M.; Vilgrain, V.; Lacroix, J.; Cuinet, M.; Taieb, S.; Aziza, R.; Sarran, A.; Labbe-Devilliers, C.; Gallix, B.; Lucidarme, O.; Ptak, Y.; Rocher, L.; Caquot, L. M.; Chagnon, S.; Marion, D.; Luciani, A.; Feutray, S.; Uzan-Augui, J.; Benatsou, B.; Bonastre, J.; Koscielny, S.
Sex specific associations in genome wide association analysis of renal cell carcinoma journalArticle 2019 Laskar, R. S.; Muller, D. C.; Li, P.; Machiela, M. J.; Ye, Y.; Gaborieau, V.; Foll, M.; Hofmann, J. N.; Colli, L.; Sampson, J. N.; Wang, Z.; Bacq-Daian, D.; Boland, A.; Abedi-Ardekani, B.; Durand, G.; Le Calvez-Kelm, F.; Robinot, N.; Blanche, H.; Prokhortchouk, E.; Skryabin, K. G.; Burdett, L.; Yeager, M.; Radojevic-Skodric, S.; Savic, S.; Foretova, L.; Holcatova, I.; Janout, V.; Mates, D.; Rascu, S.; Mukeria, A.; Zaridze, D.; Bencko, V.; Cybulski, C.; Fabianova, E.; Jinga, V.; Lissowska, J.; Lubinski, J.; Navratilova, M.; Rudnai, P.; Swiatkowska, B.; Benhamou, S.; Cancel-Tassin, G.; Cussenot, O.; Trichopoulou, A.; Riboli, E.; Overvad, K.; Panico, S.; Ljungberg, B.; Sitaram, R. T.; Giles, G. G.; Milne, R. L.; Severi, G.; Bruinsma, F.; Fletcher, T.; Koppova, K.; Larsson, S. C.; Wolk, A.; Banks, R. E.; Selby, P. J.; Easton, D. F.; Pharoah, P.; Andreotti, G.; Beane Freeman, L. E.; Koutros, S.; Albanes, D.; Mannisto, S.; Weinstein, S.; Clark, P. E.; Edwards, T. L.; Lipworth, L.; Carol, H.;
Antiangiogenic Tyrosine Kinase Inhibitors: Occurrence and Risk Factors of Hemoptysis in Refractory Thyroid Cancer journalArticle 2016 Lamartina, L.; Ippolito, S.; Danis, M.; Bidault, F.; Borget, I.; Berdelou, A.; Al Ghuzlan, A.; Hartl, D.; Blanchard, P.; Terroir, M.; Deandreis, D.; Schlumberger, M.; Baudin, E.; Leboulleux, S.
Follow-up of differentiated thyroid cancer - what should (and what should not) be done journalArticle 2018 Lamartina, L.; Grani, G.; Durante, C.; Borget, I.; Filetti, S.; Schlumberger, M.
Apport clinique des méta-analyses dans les cancers ORL localement avancés. Dirigée par Jean-Pierre Pignon & Pierre Blanchard thesis Lacas Benjamin
Impact of time to local recurrence on the occurrence of metastasis in breast cancer patients treated with neoadjuvant chemotherapy: A random forest survival approach journalArticle 2019 Laas, E.; Hamy, A. S.; Michel, A. S.; Panchbhaya, N.; Faron, M.; Lam, T.; Carrez, S.; Pierga, J. Y.; Rouzier, R.; Lerebours, F.; Feron, J. G.; Reyal, F.
Multivariate joint frailty model for the analysis of nonlinear tumor kinetics and dynamic predictions of death journalArticle 2018 Krol, A.; Tournigand, C.; Michiels, S.; Rondeau, V.
Joint model for left-censored longitudinal data, recurrent events and terminal event: Predictive abilities of tumor burden for cancer evolution with application to the FFCD 2000-05 trial journalArticle 2016 Krol, A.; Ferrer, L.; Pignon, J. P.; Proust-Lima, C.; Ducreux, M.; Bouche, O.; Michiels, S.; Rondeau, V.
Joint model for left-censored longitudinal data, recurrent events and terminal event: Predictive abilities of tumor burden for cancer evolution with application to the FFCD 2000-05 trial journalArticle 2016 Krol, A.; Ferrer, L.; Pignon, J. P.; Proust-Lima, C.; Ducreux, M.; Bouche, O.; Michiels, S.; Rondeau, V.
Trends in Management of Oligometastatic Hormone-Sensitive Prostate Cancer journalArticle 2019 Kothari, G.; Ost, P.; Cheung, P.; Blanchard, P.; Tree, A. C.; van As, N. J.; Lo, S. S.; Moghanaki, D.; Loblaw, A.; Siva, S.
Added Value of Whole-Exome and Transcriptome Sequencing for Clinical Molecular Screenings of Advanced Cancer Patients With Solid Tumors journalArticle 2018 Koeppel, F.; Bobard, A.; Lefebvre, C.; Pedrero, M.; Deloger, M.; Boursin, Y.; Richon, C.; Chen-Min-Tao, R.; Robert, G.; Meurice, G.; Rouleau, E.; Michiels, S.; Massard, C.; Scoazec, J. Y.; Solary, E.; Soria, J. C.; André, F.; Lacroix, L.
Scoring of tumor-infiltrating lymphocytes: From visual estimation to machine learning journalArticle 2018 Klauschen, F.; Müller, K. R.; Binder, A.; Bockmayr, M.; Hägele, M.; Seegerer, P.; Wienert, S.; Pruneri, G.; de Maria, S.; Badve, S.; Michiels, S.; Nielsen, T. O.; Adams, S.; Savas, P.; Symmans, F.; Willis, S.; Gruosso, T.; Park, M.; Haibe-Kains, B.; Gallas, B.; Thompson, A. M.; Cree, I.; Sotiriou, C.; Solinas, C.; Preusser, M.; Hewitt, S. M.; Rimm, D.; Viale, G.; Loi, S.; Loibl, S.; Salgado, R.; Denkert, C.
A Case-Control Study Brings to Light the Causes of Screen Failures in Phase 1 Cancer Clinical Trials journalArticle 2016 Kempf, E.; Lemoine, N.; Tergemina-Clain, G.; Turpin, A.; Postel-Vinay, S.; Lanoy, E.; Soria, J. C.; Massard, C.; Hollebecque, A.